產(chǎn)品名稱 | CTDSPL蛋白抗體 |
英文名稱 | Anti-CTDSPL |
規(guī)格 | 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來(lái)電可享受優(yōu)惠 |
英文名稱 Anti-CTDSPL
中文名稱 CTDSPL蛋白抗體
濃 度 1mg/1ml
規(guī) 格 0.2ml/200μg
抗體來(lái)源 Rabbit
克隆類型 polyclonal
交叉反應(yīng) Human, Mouse, Rat, Chicken, Pig, Cow, Horse, Sheep
產(chǎn)品類型 一抗
研究領(lǐng)域 細(xì)胞生物 染色質(zhì)和核信號(hào) 神經(jīng)生物學(xué) 信號(hào)轉(zhuǎn)導(dǎo) 表觀遺傳學(xué)
蛋白分子量 predicted molecular weight: 31kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from huCTDSPL
亞 型 IgG
純化方法 affinity purified by Protein A
儲(chǔ) 存 液 Preservative: 15mM Soium zde, Constituents: 1% BSA,0.01M PBS, pH 7.4
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -266 °C for oneyear.
別 名 Carboxy-terminal domain RNA polymerase II polypeptideA small phosphatase 3; CTD small phosphatase-like protein; CTDSL_HUMAN;CTDSP-like; Ctdspl; hYA22; NIF-like protein; NLI-interacting factor 1; NuclearLIM interactor-interacting factor 1; Protein YA22; RBSP3; SCP3; SmallC-terminal domain phosphatase 3; Small CTD phosphatase 3.
